GenSight Biologics S.A.

GSGTF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$14-$26-$28-$29
Dep. & Amort.$1$2$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$1-$3$5
Change in WC$1$2-$4$5
Other Non-Cash-$2-$4$0$1
Operating Cash Flow-$13-$25-$34-$17
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0-$0
Financing Activities
Debt Repay.-$2$13$3-$4
Stock Issued$17$4$0$0
Stock Repurch.-$0-$0-$0-$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1-$1-$3$27
Financing Cash Flow$14$16$0$24
Forex Effect-$0$0-$0-$0
Net Chg. in Cash$0-$8-$34$6
Supplemental Information
Beg. Cash$2$11$44$38
End Cash$2$2$11$44
Free Cash Flow-$13-$25-$34-$17